Document

Safe Use Symposium: A Focus on Reducing Preventable Harm From Drugs in the Outpatient Setting

The Food and Drug Administration's (FDA or Agency) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff (PASES), is hosting a 1-day pub...

The Food and Drug Administration's (FDA or Agency) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff (PASES), is hosting a 1-day public symposium entitled ``Safe Use Symposium: A Focus on Reducing Preventable Harm From Drugs in the Outpatient Setting.'' The purpose of this symposium is to discuss sources of preventable harm from drugs in the outpatient setting and to stimulate the exchange of ideas among thought leaders on interventions to reduce preventable harms and how these interventions can be studied.

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

82 FR 18910

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Safe Use Symposium: A Focus on Reducing Preventable Harm From Drugs in the Outpatient Setting,” thefederalregister.org (April 24, 2017), https://thefederalregister.org/documents/2017-08182/safe-use-symposium-a-focus-on-reducing-preventable-harm-from-drugs-in-the-outpatient-setting.